Wuxi Bio announced that the company noted that a procedural ...
Wuxi Bio announced that the company noted that a procedural hearing about a revised draft bill was held by the U.S. Senate.
Wuxi Bio's share price extended further decline to 21% in HK in the afternoon session.
The company reiterated that it is not a subsidiary of WUXI Apptec and does not have a human genomics business, nor does it collect human genomic data in any of its businesses.
Wuxi Bio's share price extended further decline to 21% in HK in the afternoon session.
The company reiterated that it is not a subsidiary of WUXI Apptec and does not have a human genomics business, nor does it collect human genomic data in any of its businesses.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
102884128 : US senate up to. doing business in US also not easy.
Smart603 102884128 : They are all sucker